Edwards Lifesciences Corp (EW) Dividend History

Company News

• Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

  Edwards Lifesciences reported strong Q1 2025 results, with sales and earnings beating expectations. The company also raised its full-year guidance, leading to an analyst upgrade citing a better growth outlook for fiscal year 2026.

  Benzinga
• Blood Pressure Monitor Market Growth USD 4.36 Billion by 2035 at a 6.1% of CAGR | Future Market Insights, Inc.

  The global blood pressure monitor market is projected to grow from USD 2.40 billion in 2025 to USD 4.36 billion by 2035, driven by aging populations, home healthcare, and AI-powered wearables. The rising prevalence of hypertension and technological advancements are key factors driving the market growth.

  GlobeNewswire Inc.

  Featured Companies: ICUI MMSI PHG
• HOLX vs. EW: Which Stock Is the Better Value Option?

  HOLX vs. EW: Which Stock Is the Better Value Option?

  Zacks Investment Research

  Featured Companies: HOLX
• Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)

  Mixed performance in the healthcare sector as Eli Lilly dominates. Edwards Lifesciences excels in transcatheter heart valve replacement and EPS growth. Read more here.

  Seeking Alpha